Future Prospective of Nanotechnology in Skin Cancer Therapeutics
Publisher
Springer Singapore
Reference67 articles.
1. Bédard, M. F., De Geest, B. G., Skirtach, A. G., Möhwald, H., & Sukhorukov, G. B. (2010). Polymeric microcapsules with light responsive properties for encapsulation and release. Advances in Colloid and Interface Science, 158(1–2), 2–14. 2. Bedikian, A. Y., Richards, J., Kharkevitch, D., Atkins, M. B., Whitman, E., & Gonzalez, R. (2010). A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma. Melanoma Research, 20(3), 218–226. 3. Bedikian, A. Y., DeConti, R. C., Conry, R., Agarwala, S., Papadopoulos, N., Kim, K. B., et al. (2011). Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. Annals of Oncology, 22(4), 787–793. 4. Bergers, G., & Benjamin, L. E. (2003). Tumorigenesis and the angiogenic switch. Nature Reviews. Cancer, 3(6), 401–410. 5. Brahimi-Horn, M. C., Bellot, G., & Pouysségur, J. (2011). Hypoxia and energetic tumour metabolism. Current Opinion in Genetics & Development, 21(1), 67–72.
|
|